Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck. - Wikidata - awgldk - TriplyDB

Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck.

Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck.

http://www.wikidata.org/entity/Q39852211

about

Thunder and lightning: immunotherapy and oncolytic viruses collide Oncogenes: The Passport for Viral Oncolysis Through PKR Inhibition Retargeting Strategies for Oncolytic Herpes Simplex Viruses CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses Viro-immune therapy: A new strategy for treatment of pancreatic cancer Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?Going viral: a review of replication-selective oncolytic adenoviruses Gene therapy for brain tumors: basic developments and clinical implementation Chemovirotherapy: combining chemotherapeutic treatment with oncolytic virotherapy Oncolytic viral therapy for pancreatic cancer: current research and future directions Role of microRNAs in hepatocellular carcinoma: a clinical perspective Design and development of a robotized system coupled to µCT imaging for intratumoral drug evaluation in a HCC mouse model Can oncology recapitulate paleontology? Lessons from species extinctions Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma.A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors.Presage of oncolytic virotherapy for oral cancer with herpes simplex virus.Replication and Oncolytic Activity of an Avian Orthoreovirus in Human Hepatocellular Carcinoma Cells.Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitors.Oncolytic viruses: From bench to bedside with a focus on safety.Oral epithelial stem cells - implications in normal development and cancer metastasis.Targeting pediatric cancer stem cells with oncolytic virotherapy Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium.A single intramuscular vaccination of mice with the HSV-1 VC2 virus with mutations in the glycoprotein K and the membrane protein UL20 confers full protection against lethal intravaginal challenge with virulent HSV-1 and HSV-2 strains.Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1 Tailored immunotherapy for HPV positive head and neck squamous cell cancer Oncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapy.Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children.Future directions and treatment strategies for head and neck squamous cell carcinomas ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma.CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma Herpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections.Trial watch: Oncolytic viruses for cancer therapy Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine.Targeting cancer stem cells with oncolytic virus Preclinical evaluation of herpes simplex virus armed with granulocyte-macrophage colony-stimulating factor in pancreatic carcinoma HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy New paradigms and future challenges in radiation oncology: an update of biological targets and technology.

P2860

Q24597894-4F8317EB-0BF6-49FC-9E84-1B2D151604A7 Q26739777-8E7C8BEC-0BF2-4645-8B40-0E0AD5DA05FA Q26765439-7D1B47D3-E5EE-4B00-85C6-4E3179D2E16B Q26766798-547372CD-633A-4C20-BEDB-83AF8A2799B1 Q26774641-311BCF09-54C5-421D-9771-94A39E0CF560 Q26775030-6572D4A1-743F-4910-92B0-3663048DEC19 Q26797520-4EA30887-FC27-4AA4-B0A2-8546D340D68A Q26829086-1BBAF9CF-6005-4314-BDDF-9A2AEE0C0DD8 Q26852345-33AFEB39-838D-4F80-8349-E3102FDB4FD7 Q27011439-E15009D2-C587-40DD-BE2B-6BC64A884FB6 Q27014034-3560FD07-9343-4F20-9914-F0681E71F486 Q27312299-DEB4610F-28D1-4416-BC89-21FFFC8A7B75 Q28607703-B05AB582-806F-4E5E-8FF4-C7A46BAE4AD2 Q30412300-6D749FBF-E62E-42B0-8F85-5BE019C39ED4 Q33437948-5E678574-63CE-4389-8B61-A581E738D639 Q33603748-0C8886A8-F1F5-4662-A1DA-A4B34FD6D81E Q33613549-A677A66C-6D66-486C-9E65-A87BD2A55250 Q33679505-B5CE46C8-F1E7-4200-B2BB-AFB53E65C3D8 Q33982322-C5AD5D2E-52D0-4518-BD3D-DF5364C9751F Q34044071-A807D059-E14F-4422-84B4-942B59CCA987 Q34147649-BE2F77B6-FB43-44DF-BBD7-52FF9988A14F Q34262327-4A5FF386-B692-47A0-B1FC-981EC6F536E8 Q34348199-26FFB84C-1CE6-4C66-8DB3-60C663090205 Q34414463-BFB881AF-9F32-407A-ABD8-728A9D5BE9A9 Q35060701-259DFEEB-A65B-4A0B-B457-2F9E6DD73A0A Q35623980-5214DC1B-A1D6-4360-A393-40245375A115 Q35823934-8BFF1C5E-4755-403E-A597-5C78299382F2 Q36109704-7572E77F-37A4-462A-8E55-9D0C9BD6BDC0 Q36177257-3D3DD4C7-253C-48A4-90BD-69916182353D Q36664273-0CE8CF76-B5E7-4098-B411-0AF8CA86B329 Q36753953-54E92611-AC3A-46DE-988E-7C56344E6CAD Q36811505-23DA8176-FE45-4629-BF98-D1983F8A8C60 Q36824210-1382FC95-F0CE-4C99-AFA6-710CFF7FA3F0 Q37028023-7A9C36B2-2FDE-47DC-BA2F-7A27910F3A20 Q37031896-E8417C89-F3E6-49C8-97A0-5469A9A2932C Q37035678-1E2272D8-4D4C-48EE-A589-1F6D1176B68E Q37044088-A884AD6A-69B0-44E4-8961-BB5BC6D5D653 Q37102488-B62239AD-5B3D-4FB0-9E8C-1395E91F36B2 Q37104963-F41B721B-91C5-429A-B9BD-14028E13F020 Q37160539-D7770BE3-6FAA-456B-A93C-11B7E5B6CFC8

P2860

Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck.

http://www.wikidata.org/entity/Q39852211

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Phase I/II study of oncolytic ...... l cancer of the head and neck.

@en

Phase I/II study of oncolytic ...... l cancer of the head and neck.

@nl

type

label

Phase I/II study of oncolytic ...... l cancer of the head and neck.

@en

Phase I/II study of oncolytic ...... l cancer of the head and neck.

@nl

prefLabel

Phase I/II study of oncolytic ...... l cancer of the head and neck.

@en

Phase I/II study of oncolytic ...... l cancer of the head and neck.

@nl

P1433

Q39852211-A60CBA2F-723C-42B4-BFD3-EE51D73C0AE9

P1476

Q39852211-570B631F-1A44-41AD-BCA8-DF021559829B

P2093

Q39852211-01EB16D8-525D-4FA5-B47F-33D190FEA35B

Q39852211-06FE7FDA-3D66-4ECB-9A95-02478AB060D9

Q39852211-11865961-C446-4A15-9C0A-F9978F700A08

Q39852211-1BD4BB42-05A7-4A2F-801E-8EEE706813AC

Q39852211-3F5B5F16-88C5-4D6D-87C8-E53E7A310B3C

Q39852211-6A88FFF4-EF72-48A4-B432-D40627EF94E4

Q39852211-6C304D18-11FC-489B-9C70-1A9BC770F6E9

Q39852211-7E6B8E5B-4815-47A2-ABBE-5E205701C205

Q39852211-8EABD78B-26AD-4F00-ADAA-32C664200789

Q39852211-93DEBE4B-91C7-4304-8F99-34E5924BC994

P304

Q39852211-4D7B131E-7268-4322-BF87-DE64DDDED350

P31

Q39852211-B9A5F976-591A-4AA5-B465-035A9EFC96B5

P356

Q39852211-C036E332-053B-40A0-93D3-A5884C5FC12B

P407

Q39852211-7082BFB7-7872-4A8F-BB97-633AB59D2FBC

P433

Q39852211-4C1619CD-E608-43F0-8FC3-CCF307EC78A6

P478

Q39852211-19E6914F-980F-4A96-B755-7A8E169D38E6

P50

Q39852211-791A4212-1738-4707-9319-5A65FFA1EC8B

Q39852211-FEE0BF9A-5072-4F06-90F7-AA36E9C4F01D

P577

Q39852211-31301C77-E1F0-42C3-8BBD-2AE6883E7103

P698

Q39852211-406DE4ED-5824-4F94-B76F-C380CD060BDE

P921

Q39852211-96A3DAA4-0FDA-4807-8EA5-954478D83FB7

P356

1078-0432.CCR-10-0196

P1433

Clinical Cancer Research

P1476

Phase I/II study of oncolytic ...... ll cancer of the head and neck

@en

P2093

Amen Sibtain

http://www.w3.org/2001/XMLSchema#string

Christopher M Nutting

http://www.w3.org/2001/XMLSchema#string

Howard Goldsweig

http://www.w3.org/2001/XMLSchema#string

Jennifer Hickey

http://www.w3.org/2001/XMLSchema#string

Kate L Newbold

http://www.w3.org/2001/XMLSchema#string

Kevin J Harrington

http://www.w3.org/2001/XMLSchema#string

Khin Thway

http://www.w3.org/2001/XMLSchema#string

Louise C Renouf

http://www.w3.org/2001/XMLSchema#string

Mary Anne Tanay

http://www.w3.org/2001/XMLSchema#string

Peter M Clarke

http://www.w3.org/2001/XMLSchema#string

P304

4005-4015

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-10-0196

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Mohan Hingorani

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20670951

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy